$5.86
0.17 (+2.99%)
Geron Corp (GERN)
CAPS Rating:
A biopharmaceutical company which is developing first-in-class therapeutic products for the treatment of cancer and chronic degenerative diseases, including spinal cord injury, heart failure, diabetes and HIV/AIDS.
RSS Headlines
Fool UK
Recs
With a new president being elected this stock will get a huge boost of government money, regardless of who the elected president. With this research the stem cell company will make great strides in curing Diabetes and other diesease making the stock profitable.
It should be added that Geron this spring has submitted to the FDA an IND (Investigational New Drug) application for a human Phase 1 trial to repair spinal chord injuries using cells derived from Embryonic Stem Cells.Supporting test data on more than two thousand spinal chord injured and treated rats, with more than 20,000 pages of data were submitted. Due to the size of the submittal the FDA is delaying the approval to proceed into human trials while they study the submitted data.Geron expects to be entering the trial by late this year.The rat models showed unprecedented recovery of spinal injuries due to the remylination of demylinated spinal nerves, the direct result of the implanted cells. In addition axon sprouting was observed.The purity of the dells was illustrated by the total lack of Teratomas in those rats injected with the pure strain of derived cells proposed for the human trials.
I wish you were right. But this stock will always plunge--it's never going to stop. As it plummets towards 0 it either end up bankrupt or bought by another biotech for .25/sh. I've held this stock for over 3 years and all it does is lose money.
those 3 yrs you held it were under a political administration that will change in a month.Lee
Hopefully, with a new president this stock will jump up as stem cell companies will be able to get funds from the government.